Purchase Order 75F40122P00409

Award Date 9/1/22
Potential Completion Date 11/30/22
Potential Value $45K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order contract award to Metabolon, Inc., a small disadvantaged business, for $151,700. The contract was awarded by the Food and Drug Administration (FDA) to provide services for the investigation of metabolomes of plasma/serum and/or urine samples to determine the utility of this approach for identifying biomarkers and/or metabolomic signatures of drug exposure and response. This contract is not set aside. Metabolon is an experienced provider of metabolomics...
This is a firm-fixed price purchase order awarded by the Department of Agriculture's Agricultural Research Service to Metabolon, Inc., a small disadvantaged business, for global metabolomics services. The contract has a potential value of $249,981.48 and a completion date of August 31, 2024. Metabolon provides specialized metabolomics analysis capabilities, including the identification and quantification of thousands of metabolites, to support biomedical research and regulatory science...
This is a firm fixed price purchase order contract awarded to Metabolon, Inc., a small disadvantaged business, by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute. The $279,378 contract is to provide metabolomics services to support the GENEFORECAST, SIT, and MHGRID research projects. Metabolon is an experienced provider of specialized metabolomics analysis capabilities for the federal government, having supported numerous...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services National Institutes of Health, to Metabolon, Inc., a self-certified small disadvantaged business, for other functions metabolic analyses of art samples. The potential value of the contract is $51,060.00, with a completion date of October 31, 2017. Metabolon is a leading provider of metabolomics solutions, offering analytical methods...
This is a $226,695.00 firm fixed price purchase order awarded by the Northeast Area division of a civilian federal agency to Metabolon, Inc., a small disadvantaged business, for metabolomic profiling of plasma samples. The contract has a period of performance through May 15, 2024. Metabolon is a leading provider of metabolomics solutions and has served as a prime contractor on numerous federal contracts, supporting research initiatives across agencies like the VA, NIH, FDA, DoD, EPA, and USDA....
This contract was awarded by the Department of the Army Medical Command to Metabolon, Inc., a self-certified small disadvantaged business, to provide global metabolomics analysis services located in Silver Spring, MD. The $147,680.00 firm fixed-price delivery order has a completion date of September 23, 2021 and was awarded on September 24, 2020. Metabolon is an experienced provider of metabolomics services to federal agencies including the Department of Veterans Affairs, National Institutes...
This firm fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) Clinical Center to Metabolon, Inc., a small disadvantaged business, to provide specialized metabolomics analysis services. The $22,080.00 contract has a period of performance ending on September 22, 2024. Metabolon has served as a prime contractor on numerous federal contracts, providing metabolic profiling of biological samples to support research initiatives across agencies such as the...
This firm fixed price purchase order contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Metabolon, Inc., a self-certified small disadvantaged business. The $124,800 contract is for a project titled "The Effect of Pre-Analytical Conditions on Metabolite Stability in Urine." Metabolon is a leading provider of metabolomics solutions and has served as both a prime contractor and subcontractor on...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a $195,000.00 firm fixed price purchase order to Metabolon, Inc., a self-certified small disadvantaged business, for the analysis of the metabolome of human pluripotent stem cells and their differentiated progeny. The contract does not have a set-aside designation. Metabolon provides metabolomics services and solutions to federal agencies like the...
This is a Firm Fixed Price Delivery Order contract awarded by the Department of the Army Medical Command to Metabolon, Inc., a self-certified small disadvantaged business. The $145,250.00 contract is for the provision of metabolomics analysis services to support various research initiatives, including areas such as veteran health, precision medicine, environmental health, drug safety, and military medicine. Metabolon has provided similar services to other federal agencies, including the...

Metabolon, Inc. was awarded a firm fixed price purchase order by the Department of Health and Human Services' Food and Drug Administration to conduct laboratory analysis for metabolomics of 90 samples across two matrixes. The $45,000 contract has no set-aside designation and requires the work be completed by November 30, 2022 in Silver Spring, Maryland. This award fulfills the requirement described in the August 15, 2022 solicitation to conduct metabolomics analysis on the specified samples to support the FDA's regulatory science and biomedical research programs. Metabolon will utilize its proprietary technology platforms to identify and quantify thousands of metabolites from the samples provided.

Generated 2/16/24, 9:04 AM